Elevated interleukin-6 in schizophrenia (Q73222786)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10579546%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

Elevated interleukin-6 in schizophrenia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10579546%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

van Kammen DP

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10579546%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

McAllister-Sistilli CG

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10579546%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Kelley ME

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10579546%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Gurklis JA

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10579546%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Yao JK

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10579546%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

language of work or name

English

0 references

publication date

1 October 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10579546%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10579546%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

87

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10579546%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

129-136

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10579546%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

2-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10579546%20AND%20SRC:MED&resulttype=core&format=json

Serum cytokine concentrations in patients with schizophrenia

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900053-0

7 January 2021

Changes in interleukin-1 beta and soluble interleukin-2 receptor levels in CSF and serum of schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900053-0

7 January 2021

The influence of cytokines on the integrity of the blood-brain barrier in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900053-0

7 January 2021

Interleukin-1 alpha and interleukin-2 in cerebrospinal fluid of schizophrenic subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900053-0

7 January 2021

Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900053-0

7 January 2021

Decreased interleukin-2 production in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900053-0

7 January 2021

Serum interleukin-6 concentration in schizophrenia: elevation associated with duration of illness

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900053-0

7 January 2021

Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900053-0

7 January 2021

Interleukin 6 modulation of second messenger systems in anterior pituitary cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900053-0

7 January 2021

Interleukin-6 as a neurotrophic factor for promoting the survival of cultured basal forebrain cholinergic neurons from postnatal rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900053-0

7 January 2021

Biological and clinical aspects of interleukin 6.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900053-0

7 January 2021

Excessive production of interleukin 6/B cell stimulatory factor-2 in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900053-0

7 January 2021

Elevated levels of interleukin-6 in cerebrospinal fluid from patients with systemic lupus erythematosus and central nervous system involvement

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900053-0

7 January 2021

Elevation of cerebrospinal fluid interleukin-6 activity in patients with vasculitides and central nervous system involvement

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900053-0

7 January 2021

Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900053-0

7 January 2021

Plasma and cerebrospinal fluid interleukin-1 beta and interleukin-6 in hospitalized schizophrenic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900053-0

7 January 2021

Plasma levels of interleukin-1 beta and interleukin-6 in schizophrenia, other psychoses, and affective disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900053-0

7 January 2021

Interleukin-6 and its receptor: a paradigm for cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900053-0

7 January 2021

The effects of psychological stress on plasma interleukin-6 activity in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900053-0

7 January 2021

Variable estimates of cytokine levels produced by commercial ELISA kits: results using international cytokine standards.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900053-0

7 January 2021

Elevated CSF levels of interleukin-2 in neuroleptic-free schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900053-0

7 January 2021

Immune-inflammatory markers in schizophrenia: comparison to normal controls and effects of clozapine

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900053-0

7 January 2021

Plasma-soluble interleukin-2 and transferrin receptor in schizoprenia and major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900053-0

7 January 2021

Interleukin-2 and interleukin-6 in schizophrenia and mania: Effects of neuroleptics and mood stabilizers

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900053-0

7 January 2021

In vivo immunomodulatory effects of clozapine in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900053-0

7 January 2021

Cytokine levels in the cerebrospinal fluid and serum of patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900053-0

7 January 2021

Neuropsychiatric aspects of cytokines research: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900053-0

7 January 2021

Elevated circulating levels of IL-6 in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900053-0

7 January 2021

A differential role for interleukin-6 and tumor necrosis factor-alpha in schizophrenia?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900053-0

7 January 2021

Effects of clozapine on plasma cytokine and soluble cytokine receptor levels

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900053-0

7 January 2021

Plasma levels of cytokines and soluble cytokine receptors during treatment with haloperidol

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900053-0

7 January 2021

Interleukin-6 mRNA expression by cortical neurons in culture: evidence for neuronal sources of interleukin-6 production in the brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900053-0

7 January 2021

Induction of neuronal differentiation in PC12 cells by B-cell stimulatory factor 2/interleukin 6

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900053-0

7 January 2021

Serum interleukin-6 in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900053-0

7 January 2021

CSF norepinephrine in schizophrenia is elevated prior to relapse after haloperidol withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900053-0

7 January 2021

Noradrenergic activity and prediction of psychotic relapse following haloperidol withdrawal in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900053-0

7 January 2021

Decreased production of interleukin-2 in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900053-0

7 January 2021

Increase of plasma IL-6 concentration with age in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900053-0

7 January 2021

Lymphocyte subsets in the blood: a diagnostic window on the lymphoid system?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900053-0

7 January 2021

IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900053-0

7 January 2021

Changes of plasma concentrations of interleukin-1 alpha and interleukin-6 with neuroleptic treatment for schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900053-0

7 January 2021

10.1016/S0165-1781(99)00053-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10579546%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference